Plain-English translation of NCT07732309 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early research study (Phase 1) testing a new medication called designed to help calm an overactive immune system in people with autoimmune diseases. The trial will start by testing different doses of the medication in small groups, then expand to larger groups once researchers find a safe dose. The main goal is to understand how well the medication works and what side effects it might cause.
People with autoimmune diseases like lupus, scleroderma, and Sjögren's syndrome struggle with treatments that don't work well enough or cause too many side effects. This trial is exploring whether this medication could offer a new, gentler option for calming the immune system.
You likely qualify if…
You likely don't qualify if…
The study happens in two phases. First, researchers test the medication at different dose levels in small groups to find the safest dose. Then, in the second phase, they give that safe dose to a larger group and watch how well it works. Throughout the study, you'll visit the clinic regularly for blood tests, check-ups, and heart monitoring to make sure the medication is working safely. The entire study will involve multiple visits over several months, and you'll continue being monitored for up to 48 weeks after you stop taking the medication.
AI-generated summary from trial data · Oct 29, 2026 · Not medical advice
China